期刊文献+

辛伐他汀对冠心病伴高血脂症患者内皮素及血小板聚集率的影响 被引量:1

下载PDF
导出
摘要 目的 探讨冠心病伴高血脂症患者抗冠心病治疗的同时行调脂治疗对内皮素 (ET)及血小板聚集率(PAG)的影响。方法  110例冠心病伴高血脂症患者随机分为 2组各 5 5例 ,在抗冠心病和调脂治疗的同时治疗组加用辛伐他汀 (5mg/d) ,观察两组治疗前及治疗 12周后血脂、ET及PAG的变化。结果  12周后 ,治疗组血清胆固醇下降 2 7% (P <0 .0 0 1) ,三酰甘油下降 14 % (P <0 .0 1) ,低密度脂蛋白胆固醇降低 2 5 % (P <0 .0 0 1) ,高密度脂蛋白胆固醇上升 11% (P <0 .0 1) ,ET及PAG显著下降 (P均 <0 .0 1)。对照组血脂水平、ET及PAG虽有下降 ,但无显著性差异。结论 冠心病伴高血脂症患者抗冠心病治疗同时加用辛伐他汀不仅可降低血脂 ,也可降低ET和PAG。
出处 《现代中西医结合杂志》 CAS 2004年第12期1573-1573,1662,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

  • 1王仁云,高建青.他汀类药物的非降脂作用及用途[J].国外医学(药学分册),2000,27(3):137-140. 被引量:16
  • 2Horio T,Kohno M,Marakawa K,et al. Increased plasma immunoreactive endothelin concentration in hypercholesterolemic rats[J]. Atherosclerosis,1991,89:239-249
  • 3Osamah H,Mria R,Sorina S,et al. Reduced Platelet aggregation after flarastatin therapy is assoliated with altered platelet lipid composition and drug binding to the platelets[J]. Br J clin Pharmacol,1997,44:77-83
  • 4吴方建.调脂药物的临床应用[J].中国医院药学杂志,2000,20(9):559-560. 被引量:4

二级参考文献12

共引文献18

同被引文献9

  • 1赵慧强,贾国良,郭文怡,王海昌,李虎,王晓燕.雷帕霉素洗脱支架对冠心病患者介入术后血小板功能的影响[J].中华老年心脑血管病杂志,2005,7(2):94-96. 被引量:3
  • 2Lip G Y,Edwards S J.Stroke prevention with aspirin,warfarin and ximelagatran in patients with non-valvular atria] fibrillation:a systematic review and Meta-analysis[J].Thromb Res,2006,118(3):321-333.
  • 3Freestone B,Lip C Y.The endothelium and atria] fibrillation.The prothrombotic state revisited[J].Hamostaseologie,2008,28(4):207-212.
  • 4Mont L,Tamborero D,Elosua R,et al.Physical activity,height,and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals[J].Europace,2008,10(1):15-20.
  • 5Lin Y S,Guo G B,Chen Y L,et al.Atrial size independently correlates with the development of paroxysmal atrial fibrillation in patients with sick sinus syndrome[J].Chang Gung Med J,2010,33(6):659-667.
  • 6Mondillo S,Sabatini L,Agricola E,et al.Correlation between left at rial size,prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation[J].Int J Cardiol,2000,75 (2-3):227-232.
  • 7Chung M K,Martin D O,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias[J].Circulation,2001,104(24):2886-2881.
  • 8Thambidoraweal S K,Parakh K,Martin DO,et al.Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation[J].Am J Cardiol,2004,94 (6):805-807.
  • 9Bonder M,Luzak B,Watala C.Role of C-reactive protein in atherogenesis[J].Postepy Hig Med Dosw(Online),2006,60:538-546.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部